Which antipsychotic is described as weight neutral and carries a risk of QT prolongation?

Enhance your preparation for the PMHNP Certification Exam with Georgette's resources. Delve into multiple-choice questions and detailed explanations to ensure you're ready for success. Boost your study efficiency and exam confidence today!

Multiple Choice

Which antipsychotic is described as weight neutral and carries a risk of QT prolongation?

Explanation:
Ziprasidone (Geodon) is the antipsychotic known for being weight neutral while carrying a risk of QT interval prolongation. It tends to cause little or no weight gain compared with many other atypical antipsychotics, which makes it appealing for metabolic concerns. At the same time, it can prolong the QT interval, so ECG monitoring and attention to electrolytes are important, especially in patients with baseline QT prolongation or those on other QT-prolonging meds. It should also be taken with meals to ensure proper absorption. The other options generally have more weight gain or different cardiac risk profiles, so they don’t fit the described combination as well.

Ziprasidone (Geodon) is the antipsychotic known for being weight neutral while carrying a risk of QT interval prolongation. It tends to cause little or no weight gain compared with many other atypical antipsychotics, which makes it appealing for metabolic concerns. At the same time, it can prolong the QT interval, so ECG monitoring and attention to electrolytes are important, especially in patients with baseline QT prolongation or those on other QT-prolonging meds. It should also be taken with meals to ensure proper absorption. The other options generally have more weight gain or different cardiac risk profiles, so they don’t fit the described combination as well.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy